[REGN] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
03-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 18.42%
YoY- 13.65%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 3,547,100 3,158,100 2,857,200 5,138,500 1,952,000 1,933,700 1,608,022 14.08%
PBT 1,628,100 1,082,900 963,200 3,752,800 918,900 224,700 656,074 16.33%
Tax 195,800 114,500 111,100 653,900 21,600 31,600 104,662 10.99%
NP 1,432,300 968,400 852,100 3,098,900 897,300 193,100 551,412 17.22%
Tax Rate -12.03% -10.57% -11.53% -17.42% -2.35% -14.06% -15.95% -
Total Cost 2,114,800 2,189,700 2,005,100 2,039,600 1,054,700 1,740,600 1,056,610 12.24%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 40.38 30.66 29.82 60.31 45.97 9.99 34.29 2.75%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS 13.25 9.05 7.47 29.51 8.19 1.77 5.12 17.15%
EPS Diluted 12.41 8.50 7.47 27.97 7.61 1.68 4.82 17.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.